Stay updated with breaking news from 80067710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on SGMO. HC Wainwright restated a buy rating and set a $5.00 price target (up previously […]
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six research firms that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) has been assigned a consensus rating of “Hold” from the seven brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. […]
HC Wainwright reissued their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $3.00 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2024 earnings at ($0.10) EPS, Q2 2024 earnings at ($0.07) […]
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to […]